Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) [Yahoo! Finance]
Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Tenaya Therapeutics, Inc. (NASDAQ: TNYA) had its price target lowered by analysts at Chardan Capital from $20.00 to $18.00. They now have a "buy" rating on the stock.
Tenaya Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
Tenaya Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update